Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6421317 | 0.87 | HDAC1 (0.50) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL27483841 | 0.86 | HDAC1 (0.51) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL5015554 | 0.81 | HDAC1 (0.55) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL2641155 | 0.81 | HDAC1 (0.52) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL2641158 | 0.81 | HDAC1 (0.52) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL5015510 | 0.81 | HDAC1 (0.55) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL12395816 | 0.81 | HDAC1 (0.52) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL6688124 | 0.78 | HDAC1 (0.54) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL12369723 | 0.78 | HDAC1 (0.54) | HDAC1HDAC6CYP2A6PPARAALDH1A1 | |
| SCHEMBL14086708 | 0.78 | HDAC1 (0.49) | HDAC1HDAC6CYP2A6PPARAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005074945-A2 | KETOLIDE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LIMITED (GB) | 2005-08-18 | — | — | WO | claimed |
| EP-1030673-B1 | USE OF KETOLIDES FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS RELATED TO ATHEROSCLEROSIS | AVENTIS PHARMA SA (FR) | 2004-07-28 | — | — | EP | claimed |
| EP-0680967-B1 | Erythromycin derivatives, their process of preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (FR) | 1998-10-14 | — | — | EP | claimed |
| WO-1995029929-A1 | NOVEL ERYTHROMYCIN DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS | ROUSSEL UCLAF (FR) | 1995-11-09 | — | — | WO | claimed |
| EP-0680967-A1 | Erythromycin derivatives, their process of preparation and their use as medicaments | ROUSSEL-UCLAF (FR) | 1995-11-08 | — | — | EP | claimed |
| WO-2005074945-A2 | KETOLIDE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LIMITED (GB) | 2005-08-18 | — | — | WO | disclosed |
| EP-1030673-B1 | USE OF KETOLIDES FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS RELATED TO ATHEROSCLEROSIS | AVENTIS PHARMA SA (FR) | 2004-07-28 | — | — | EP | disclosed |
| EP-0680967-B1 | Erythromycin derivatives, their process of preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (FR) | 1998-10-14 | — | — | EP | disclosed |
| EP-0680967-A1 | Erythromycin derivatives, their process of preparation and their use as medicaments | ROUSSEL-UCLAF (FR) | 1995-11-08 | — | — | EP | disclosed |